Comparison of phenotypic and genotypic approaches to capsule typing of neisseria meningitidis by use of invasive and carriage isolate collections

Journal of Clinical Microbiology

Volumn 54, Issue 1, 2016, Pages 25-34

  Jones, C Hal ^a   Mohamed, Naglaa ^a   Rojas, Eduardo ^a   Andrew, Lubomira ^a   Hoyos, Johanna ^a   Hawkins, Julio C ^a   McNeil, Lisa K ^a   Jiang, Qin ^a   Mayer, Leonard W ^b   Wang, Xin ^b   Gilca, Rodica ^c,d,e   De Wals, Philippe ^c,d,e   Pedneault, Louise ^a   Eiden, Joseph ^a   Jansen, Kathrin U ^a   Anderson, Annaliesa S ^a  

^a Vaccine Research East and Early Development   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DOT BLOTTING; FALSE POSITIVE RESULT; FLUORESCENCE ACTIVATED CELL SORTING; IN VITRO STUDY; INTERMETHOD COMPARISON; INVASIVE MENINGOCOCCAL DISEASE; LIVE CELL PHENOTYPIC ASSAY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROTYPE; WHOLE GENOME SEQUENCING; ADOLESCENT; ADULT; BACTERIAL CAPSULE; CLASSIFICATION; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPING TECHNIQUE; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; NEISSERIACEAE INFECTION; PROCEDURES; SEROTYPING; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIAL CAPSULES; CARRIER STATE; EPIDEMIOLOGIC STUDIES; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTIONS; SEROTYPING; YOUNG ADULT;

EID: 84954339119     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01447-15     Document Type: Article

References (98)

1. Caugant DA, Maiden MCJ. 2009. Meningococcal carriage and disease: population biology and evolution. Vaccine 27(Suppl 2):B64-B70. http://dx.doi.org/10.1016/j.vaccine.2009.04.061.
2. MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM. 2006. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 12:950-957. http://dx.doi.org/10.3201/eid1206.051297.
3. Yazdankhah SP, Caugant DA. 2004. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 53:821-832. http://dx.doi.org/10.1099/jmm.0.45529-0.
4. Caugant DA, Hoiby EA, Magnus P, Scheel O, Hoel T, Bjune G, Wedege E, Eng J, Froholm LO. 1994. Asymptomatic carriage of Neisseria menin-gitidis in a randomly sampled population. J Clin Microbiol 32:323-330.
5. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, Hessler F, Frosch M, Vogel U. 2005. Genetic analysis of meningococci carried by children and young adults. J Infect Dis 191:1263-1271. http://dx.doi.org/10.1086/428590.
6. Stephens DS. 1999. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 353:941-942. http://dx.doi.org/10.1016/S0140-6736(98)00279-7.
7. Cartwright K. 1995. The clinical spectrum of meningococcal disease, p 115-146. In Cartwright K (ed), Meningococcal disease. John Wiley & Sons, Chichester, United Kingdom.
8. Olcen P, Kjellander J, Danielsson D, Lindquist BL. 1981. Epidemiology of Neisseria meningitidis: prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 13:105-109. http://dx.doi.org/10.3109/inf.1981.13.issue-2.05.
9. Kremastinou J, Tzanakaki G, Levidiotou S, Markou F, Themeli E, Voyiatzi A, Psoma E, Theodoridou M, Blackwell CC. 2003. Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece. FEMS Immunol Med Microbiol 39:23-29. http://dx.doi.org/10.1016/S0928-8244(03)00174-3.
10. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. 2001. Meningococcal disease. N Engl J Med 344:1378-1388. http://dx.doi.org/10.1056/NEJM200105033441807.
11. Edwards EA, Devine LF, Sengbusch GH, Ward HW. 1977. Immuno-logical investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis 9:105-110.
12. Christensen H, Trotter CL, Hickman M, Edmunds WJ. 2014. Reevaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ 349:g5725. http://dx.doi.org/10.1136/bmj.g5725.
13. Anderson AS, Hao L, Jiang Q, Harris SL, Jones TR, Perez JL, York L, Eiden J, Jansen KU. 2013. Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease. Hum Vaccin Immunother 9:471-479.
14. Centers for Disease Control and Prevention. 2013. Active Bacterial Core Surveillance report, Emerging Infections Program Network, Neisseria meningitidis, 2012. Centers for Disease Control and Prevention, Atlanta, GA http://www.cdc.gov/abcs/reports-findings/survreports/mening12.pdf
15. Li Y, Tsang R, Desai S, Deehan H. 2014. Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011. Can Commun Dis Rep 40:160.
16. European Centre for Disease Prevention and Control. 2015. Annual epidemiological report 2014: vaccine-preventable diseases: invasive bacterial diseases. European Centre for Disease Prevention and Control, Stockholm, Sweden. http://ecdc.europa.eu/en/publications/Publications/AER-VPD-IBD-2014.pdf
17. Dwilow R, Fanella S. 2015. Invasive meningococcal disease in the 21st century: an update for the clinician. Curr Neurol Neurosci Rep 15:2. http://dx.doi.org/10.1007/s11910-015-0524-6.
18. McNamara LA, Shumate AM, Johnsen P, MacNeil JR, Patel M, Bhavsar T, Cohn AC, Dinitz-Sklar J, Duffy J, Finnie J, Garon D, Hary R, Hu F, Kamiya H, Kim HJ, Kolligian J, Jr, Neglia J, Oakley J, Wagner J, Wagner K, Wang X, Yu Y, Montana B, Tan C, Izzo R, Clark TA. 2015. First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics 135:798-804. http://dx.doi.org/10.1542/peds.2014-4015.
19. Tzeng YL, Stephens DS. 2000. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2:687-700. http://dx.doi.org/10.1016/S1286-4579(00)00356-7.
20. Kahler CM, Martin LE, Shih GC, Rahman MM, Carlson RW, Stephens DS. 1998. The (a 8)-linked polysialic acid capsule and lipooligosaccha-ride structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun 66:5939-5947.
21. Vogel U, Frosch M. 1999. Mechanisms of neisserial serum resistance. Mol Microbiol 32:1133-1139. http://dx.doi.org/10.1046/j.1365-2958.1999.01469.x
22. Branham SE. 1953. Serological relationships among meningococci. Bacteriol Rev 17:175-188.
23. Craven DE, Frasch CE, Robbins JB, Feldman HA. 1978. Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol 7:410-414.
24. Khatami A, Pollard AJ. 2010. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 9:285-298. http://dx.doi.org/10.1586/erv.10.3.
25. Harrison LH. 2006. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 19:142-164. http://dx.doi.org/10.1128/CMR.19.1.142-164.2006.
26. Maiden MC, Begg NT. 2001. Overview: epidemiology, surveillance, and population biology, p 121-130. In Pollard AJ, Maiden MCJ (ed), Methods in molecular medicine, vol 67: Meningococcal disease methods and protocols. Humana Press, Totowa, NJ.
27. World Health Organization. 2011. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, 2nd ed. World Health Organization, Geneva, Switzerland.
28. Borrow R, Abad R, Trotter C, van der Klis FR, Vazquez JA. 2013. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine 31:4477-4486. http://dx.doi.org/10.1016/j.vaccine.2013.07.083.
29. Trotter CL, Ramsay ME. 2007. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol Rev 31:101-107. http://dx.doi.org/10.1111/j.1574-6976.2006.00053.x.
30. Finne J, Leinonen M, Makela PH. 1983. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet ii:355-357.
31. Zlotnick GW, Jones TR, Liberator P, Hao L, Harris S, McNeil LK, Zhu D, Perez J, Eiden J, Jansen KU, Anderson AS. 2015. The discovery and development of a novel vaccine to protect against Neisseria meningitidis serogroup B disease. Hum Vaccin Immunother 11:5-13. http://dx.doi.org/10.4161/hv.34293.
32. The Medical Letter. 2015. Trumenba: a serogroup B meningococcal vaccine. Med Lett Drugs Ther 57:5-6.
33. Food and Drug Administration. 2015. FDA approves a second vaccine to prevent serogroup B meningococcal disease. Food and Drug Administration, Washington, DC. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm431370.htm.
34. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D. 2012. Effect of vaccines on bacterial meningitis worldwide. Lancet 380:1703-1711. http://dx.doi.org/10.1016/S0140-6736(12)61187-8.
35. Trotter CL, Maiden MC. 2009. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 8:851-861. http://dx.doi.org/10.1586/erv.09.48.
36. Bijlsma MW, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A. 2014. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination. Clin Infect Dis 59:1216-1221. http://dx.doi.org/10.1093/cid/ciu601.
37. Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA. 2014. The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012. Clin Infect Dis 59:1208-1215. http://dx.doi.org/10.1093/cid/ciu597.
38. Roderick M, Finn A. 2014. Advances towards the prevention of menin-gococcal B disease: a multidimensional story. J Infect 68(Suppl 1):S76-S82. http://dx.doi.org/10.1016/j.jinf.2013.09.026.
39. Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, Heath PT, Lewis DJ, Pollard AJ, Turner DP, Bazaz R, Ganguli A, Havelock T, Neal KR, Okike IO, Morales-Aza B, Patel K, Snape MD, Williams J, Gilchrist S, Gray SJ, Maiden MC, Toneatto D, Wang H, McCarthy M, Dull PM, BorrowR. 2014. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococ-cal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet 384:2123-2131. http://dx.doi.org/10.1016/S0140-6736(14)60842-4.
40. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, Mayer LW, Phelan M, Taylor TH, Jr, Bernhardt SA, Rosenstein NE, Popovic T. 2004. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria men-ingitidis. J Clin Microbiol 42:320-328. http://dx.doi.org/10.1128/JCM.42.1.320-328.2004.
41. Zollinger WD, Moran EE, Connelly H, Mandrell RE, Brandt B. 1984. Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping. Infect Im-mun 46:260-266.
42. Abdillahi H, Poolman JT. 1988. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol 26:177-180.
43. McNeil LK, Murphy E, Zhao XJ, Guttmann S, Harris SL, Scott AA, Tan C, Mack M, DaSilva I, Alexander K, Mason K, Jiang HQ, Zhu D, Mininni TL, Zlotnick GW, Hoiseth SK, Jones TR, Pride MW, Jansen KU, Anderson AS. 2009. Detection of LP2086 on the cell surface of Neis-seria meningitidis and its accessibility in the presence of serogroup B cap-sular polysaccharide. Vaccine 27:3417-3421. http://dx.doi.org/10.1016/j.vaccine.2009.01.075.
44. Hammerschmidt S, Muller A, Sillmann H, Muhlenhoff M, Borrow R, Fox A, van Putten J, Zollinger WD, Gerardy-Schahn R, Frosch M. 1996. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 20:1211-1220. http://dx.doi.org/10.1111/j.1365-2958.1996.tb02641.x.
45. Sadler F, Fox A, Neal K, Dawson M, Cartwright K, Borrow R. 2003. Genetic analysis of capsular status of meningococcal carrier isolates. Epidemiol Infect 130:59-70. http://dx.doi.org/10.1017/S0950268802007987.
46. Tzeng YL, Swartley JS, Miller YK, Nisbet RE, Liu LJ, Ahn JH, Stephens DS. 2001. Transcriptional regulation of divergent capsule biosynthesis and transport operon promoters in serogroup B Neisseria meningitidis. Infect Immun 69:2502-2511. http://dx.doi.org/10.1128/IAI.69.4.2502-2511.2001.
47. Von Loewenich FD, Wintermeyer E, Dumig M, Frosch M. 2001. Analysis of transcriptional control mechanisms of capsule expression in Neis-seria meningitidis. Int J Med Microbiol 291:361-369. http://dx.doi.org/10.1078/1438-4221-00142.
48. Hammerschmidt S, Hilse R, van Putten JP, Gerardy-Schahn R, Unk-meir A, Frosch M. 1996. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 15: 192-198.
49. Hoang LM, Thomas E, Tyler S, Pollard AJ, Stephens G, Gustafson L, McNabb A, Pocock I, Tsang R, Tan R. 2005. Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus. Clin Infect Dis 40:e38-e42. http://dx.doi.org/10.1086/427875.
50. Claus H, Maiden MC, Maag R, Frosch M, Vogel U. 2002. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148:1813-1819. http://dx.doi.org/10.1099/00221287-148-6-1813.
51. Loh E, Kugelberg E, Tracy A, Zhang Q, Gollan B, Ewles H, Chalmers R, Pelicic V, Tang CM. 2013. Temperature triggers immune evasion by Neisseria meningitidis. Nature 502:237-240. http://dx.doi.org/10.1038/nature12616.
52. Frosch M, Weisgerber C, Meyer TF. 1989. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci USA 86:1669-1673. http://dx.doi.org/10.1073/pnas.86.5.1669.
53. Swartley JS, Liu LJ, Miller YK, Martin LE, Edupuganti S, Stephens DS. 1998. Characterization of the gene cassette required for biosynthesis of the (a1 6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of sero-group A Neisseria meningitidis. J Bacteriol 180:1533-1539.
54. Edwards U, Muller A, Hammerschmidt S, Gerardy-Schahn R, Frosch M. 1994. Molecular analysis of the biosynthesis pathway of the a-2, 8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol 14:141-149. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01274.x.
55. Frosch M, Edwards U, Bousset K, Krausse B, Weisgerber C. 1991. Evidence for a common molecular origin of the capsule gene loci in Gram-negative bacteria expressing group II capsular polysaccharides. Mol Microbiol 5:1251-1263. http://dx.doi.org/10.1111/j.1365-2958.1991.tb01899.x.
56. Frosch M, Muller D, Bousset K, Muller A. 1992. Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression. Infect Immun 60:798-803.
57. Ala'Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, Hawkey PM, Slack RC. 2000. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 38:2311-2316.
58. Borrow R, Claus H, Chaudhry U, Guiver M, Kaczmarski EB, Frosch M, Fox AJ. 1998. siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett 159:209-214. http://dx.doi.org/10.1111/j.1574-6968.1998.tb12862.x.
59. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39:1553-1558. http://dx.doi.org/10.1128/JCM.39.4.1553-1558.2001.
60. Lewis C, Clarke SC. 2003. Identification of Neisseria meningitidis sero-groups Y and W135 by siaD nucleotide sequence analysis. J Clin Microbiol 41:2697-2699. http://dx.doi.org/10.1128/JCM.41.6.2697-2699.2003.
61. Taha MK, Alonso JM, Cafferkey M, Caugant DA, Clarke SC, Diggle MA, Fox A, Frosch M, Gray SJ, Guiver M, Heuberger S, Kalmusova J, Kesanopoulos K, Klem AM, Kriz P, Marsh J, Molling P, Murphy K, Olcen P, Sanou O, Tzanakaki G, Vogel U. 2005. Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol 43:144-149. http://dx.doi.org/10.1128/JCM.43.1.144-149.2005.
62. Probert WS, Bystrom SL, Khashe S, Schrader KN, Wong JD. 2002. 5' Exonuclease assay for detection of serogroup Y Neisseria meningitidis. J Clin Microbiol 40:4325-4328. http://dx.doi.org/10.1128/JCM.40.11.4325-4328.2002.
63. Drakopoulou Z, Kesanopoulos K, Sioumala M, Tambaki A, Kremasti-nou J, Tzanakaki G. 2008. Simultaneous single-tube PCR-based assay for the direct identification of the five most common meningococcal sero-groups from clinical samples. FEMS Immunol Med Microbiol 53:178-182. http://dx.doi.org/10.1111/j.1574-695X.2008.00406.x.
64. Borrow R, Claus H, Guiver M, Smart L, Jones DM, Kaczmarski EB, Frosch M, Fox AJ. 1997. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect 118:111-117. http://dx.doi.org/10.1017/S0950268896007261.
65. Taha MK. 2000. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38:855-857.
66. Pollard AJ, Probe G, Trombley C, Castell A, Whitehead S, Bigham JM, Champagne S, Isaac-Renton J, Tan R, Guiver M, Borrow R, Speert DP, Thomas E. 2002. Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Arch Pathol Lab Med 126:1209-1215.
67. Diggle MA, Smith K, Girvan EK, Clarke SC. 2003. Evaluation of a fluorescence-based PCR method for identification of serogroup A meningococci. J Clin Microbiol 41:1766-1768. http://dx.doi.org/10.1128/JCM.41.4.1766-1768.2003.
68. Rojas E, Hoyos J, Oldfield NJ, Lee P, Flint M, Jones CH, Ala'Aldeen DA, Jansen KU, Anderson AS. 2015. Optimization of molecular approaches to genogroup Neisseria meningitidis carriage isolates and implications for monitoring the impact of new serogroup B vaccines. PLoS One 10: e0132140. http://dx.doi.org/10.1371/journal.pone.0132140.
69. Jolley KA, Hill DM, Bratcher HB, Harrison OB, Feavers IM, Parkhill J, Maiden MC. 2012. Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods. J Clin Microbiol 50:3046-3053. http://dx.doi.org/10.1128/JCM.01312-12.
70. Koser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M, Enright MC, Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR, Schulz-Trieglaff OB, Smith GP, Peacock SJ. 2012. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 366:2267-2275. http://dx.doi.org/10.1056/NEJMoa1109910.
71. Jolley KA, Maiden MCJ. 2013. Automated extraction of typing information for bacterial pathogens from whole genome sequence data: Neisseria meningitidis as an exemplar. Eur Surveill 18:pii=20379. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20379.
72. Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS. 2013. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups. Pediatr Infect Dis J 32:1096-1101. http://dx.doi.org/10.1097/INF.0b013e31829aa63b.
73. Gilca R, De Wals P, Costa JA, Nolan SM, Eiden J, Pregaldien JL, Jiang Q, Jones H, Jansen KU, Anderson AS, Pedneault L. 2013. Longitudinal study of Neisseria meningitidis oropharyngeal carriage in adolescents and young adults in Québec City, Canada, abstr 10. EMGM-Eur Meningococcal Dis Soc 2013, Bad Loipersdorf, Austria, 17 to 19 September 2013.
74. Kellogg DS, Jr, Peacock WL, Jr, Deacon WE, Brown L, Pirkle DI. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J Bacteriol 85:1274-1279.
75. Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. http://dx.doi.org/10.1186/1471-2105-11-595.
76. Jordens JZ, Heckels JE. 2005. A novel porA-based real-time PCR for detection of meningococcal carriage. J Med Microbiol 54:463-466. http://dx.doi.org/10.1099/jmm.0.45847-0.
77. Jordens JZ, Williams JN, Jones GR, Heckels JE. 2002. Detection of meningococcal carriage by culture and PCR of throat swabs and mouth gargles. J Clin Microbiol 40:75-79. http://dx.doi.org/10.1128/JCM.40.1.75-79.2002.
78. Longworth E, Fernsten P, Mininni TL, Vogel U, Claus H, Gray S, Kaczmarski E, Borrow R. 2002. O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK. FEMS Immunol Med Microbiol 32:119-123. http://dx.doi.org/10.1111/j.1574-695X.2002.tb00543.x.
79. Collett D. 1991. Modelling binary data. Chapman and Hall, London, United Kingdom.
80. Weber MV, Claus H, Maiden MC, Frosch M, Vogel U. 2006. Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers. Int J Med Microbiol 296:475-484. http://dx.doi.org/10.1016/j.ijmm.2006.05.004.
81. Claus H, Borrow R, Achtman M, Morelli G, Kantelberg C, Longworth E, Frosch M, Vogel U. 2004. Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci. Mol Microbiol 51:227-239.
82. Kugelberg E, Gollan B, Farrance C, Bratcher H, Lucidarme J, Ibarz-Pavon AB, Maiden MC, Borrow R, Tang CM. 2010. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. PLoS One 5:e9413. http://dx.doi.org/10.1371/journal.pone.0009413.
83. Schork S, Schluter A, Blom J, Schneiker-Bekel S, Puhler A, Goesmann A, Frosch M, Schoen C. 2012. Genome sequence of a Neisseria meningi-tidis capsule null locus strain from the clonal complex of sequence type 198. J Bacteriol 194:5144-5145. http://dx.doi.org/10.1128/JB.01099-12.
84. Dolan-Livengood JM, Miller YK, Martin LE, Urwin R, Stephens DS. 2003. Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis 187:1616-1628. http://dx.doi.org/10.1086/374740.
85. Parkhill J, Achtman M, James KD, Bentley SD, Churcher C, Klee SR, Morelli G, Basham D, Brown D, Chillingworth T, Davies RM, Davis P, Devlin K, Feltwell T, Hamlin N, Holroyd S, Jagels K, Leather S, Moule S, Mungall K, Quail MA, Rajandream MA, Rutherford KM, Simmonds M, Skelton J, Whitehead S, Spratt BG, Barrell BG. 2000. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404:502-506. http://dx.doi.org/10.1038/35006655.
86. Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade BM, Claus H, Gray SJ, Yaro S, Traore Y, Sangare L, Nicolas P, Gessner BD, Borrow R. 2007. Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. J Infect Dis 195:1071-1077. http://dx.doi.org/10.1086/512084.
87. Johswich KO, Zhou J, Law DK, St Michael F, McCaw SE, Jamieson FB, Cox AD, Tsang RS, Gray-Owen SD. 2012. Invasive potential of nonen-capsulated disease isolates of Neisseria meningitidis. Infect Immun 80: 2346-2353. http://dx.doi.org/10.1128/IAI.00293-12.
88. Hill DJ, Griffiths NJ, Borodina E, Virji M. 2010. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci 118:547-564. http://dx.doi.org/10.1042/CS20090513.
89. Unkmeir A, Kammerer U, Stade A, Hubner C, Haller S, Kolb-Maurer A, Frosch M, Dietrich G. 2002. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine menin-gococcal interaction with human dendritic cells. Infect Immun 70:2454-2462. http://dx.doi.org/10.1128/IAI.70.5.2454-2462.2002.
90. Lewis LA, Ram S. 2014. Meningococcal disease and the complement system. Virulence 5:98-126. http://dx.doi.org/10.4161/viru.26515.
91. Vogel U, Claus H, Frosch M. 2004. Genetic lineages and their traits in Neisseria meningitidis. Int J Med Microbiol 294:75-82. http://dx.doi.org/10.1016/j.ijmm.2004.06.027.
92. Putonti C, Nowicki B, Shaffer M, Fofanov Y, Nowicki S. 2013. Where does Neisseria acquire foreign DNA from: an examination of the source of genomic and pathogenic islands and the evolution of the Neisseria genus. BMC Evol Biol 13:184. http://dx.doi.org/10.1186/1471-2148-13-184.
93. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, Wenger JD, Stephens DS. 1997. Capsule switching of Neisseria meningi-tidis. Proc Natl Acad Sci USA 94:271-276. http://dx.doi.org/10.1073/pnas.94.1.271.
94. Kriz P, Giorgini D, Musilek M, Larribe M, Taha MK. 1999. Microevo-lution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res Microbiol 150: 273-280. http://dx.doi.org/10.1016/S0923-2508(99)80052-7.
95. Vogel U, Claus H, Frosch M. 2000. Rapid serogroup switching in Neis-seria meningitidis. N Engl J Med 342:219-220. http://dx.doi.org/10.1056/NEJM200001203420319.
96. Harrison LH, Shutt KA, Schmink SE, Marsh JW, Harcourt BH, Wang X, Whitney AM, Stephens DS, Cohn AA, Messonnier NE, Mayer LW. 2010. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era-United States, 2000-2005. J Infect Dis 201:1208-1224. http://dx.doi.org/10.1086/651505.
97. Dolan Thomas J, Hatcher CP, Satterfield DA, Theodore MJ, Bach MC, Linscott KB, Zhao X, Wang X, Mair R, Schmink S, Arnold KE, Stephens DS, Harrison LH, Hollick RA, Andrade AL, Lamaro-Cardoso J, de Lemos AP, Gritzfeld J, Gordon S, Soysal A, Bakir M, Sharma D, Jain S, Satola SW, Messonnier NE, Mayer LW. 2011. sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One 6:e19361. http://dx.doi.org/10.1371/journal.pone.0019361.
98. Higa FT, Fukasawa LO, Goncalves MG, Salgado MM, Lemos AP, Harrison LH, Oliveira PL, Silva CN, Sacchi CT. 2013. Use of sodC versus ctrA for real-time polymerase chain reaction-based detection of Neisseria meningitidis in sterile body fluids. Mem Inst Oswaldo Cruz 108:246-247. http://dx.doi.org/10.1590/0074-0276108022013020.